Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Identifying the mechanism of action of the Kv7 channel opener, retigabine in the treatment of epilepsy

Zahra, Aqeela, Liu, Ru, Wang, Jingjing, Wu, Jianping · 2023 · Neurological Sciences

Abstract

Epilepsy is characterized by recurrent epileptic seizures caused by high levels of neuronal excitability in the brain. Voltage-sensitive K+ channels (Kv) of the Kv7 (KCNQ) family encoded by the KCNQ gene are involved in a wide range of cellular processes, i.e., KCNQ2 and KCNQ3 channels mediate M-currents to inhibit neuronal excitability and reduce transmitter release throughout the nervous system. Thus, as a positive allosteric modulator (or opener) of KCNQ channels, retigabine has been the only clinically approved anti-seizure medication that acts on the KCNQ channels. This review discusses the biochemical mechanisms about how retigabine acts on Kv7 channels, significance in neuronal pathophysiology, preclinical efficacy, and clinical stage of development. Additional efforts are being made to emphasize the possible benefits and drawbacks of retigabine compared to currently available medications for treatment-resistant epilepsy.

Overview

Integrity signals

Registry

Crossref · 10.1007/s10072-023-06955-x

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 66 references

Research works printed but not linked: 5

  1. Serrano-Albarrás A (2018) Heteromeric composition of the Kv 1.3 channelosome= Composició heteromèrica del canalosoma Kv1. 3. Dissertation, Universitat de Barcelona
  2. Niday Z, Tzingounis AV (2018) Potassium channel gain of function in epilepsy: an unresolved paradox. Neurosci 24:368–380
  3. Cox R, McGowran M (2002) Society for Neuroscience-32nd Annual Meeting. IDrugs Investig drugs J 5:1095–1098
  4. Rundfeldt C (1995) Multiple actions of the new anticonvulsant D-23129 on voltage-gated inward currents and GABA-induced currents in cultured neuronal cells. Naunyn Schmiedeberg's Arch Pharmacol 351:R160
  5. Hermann R, Borlak J, Munzel U et al (2006) The role of Gilbert’s syndrome and frequent NAT2 slow acetylation polymorphisms in the pharmacokinetics of retigabine. Pharm J 6:211–219

Cited by

See all 9

Metadata

Authors
Zahra, A., Liu, R., Wang, J., & Wu, J.
Affiliations
  • Wuhan University of Technology (CN)
  • Capital Medical University (CN)
Corresponding author
Wu, Jianping
Venue
Neurological Sciences
Published
2023-07-13
Volume
44
Issue
11
Pages
3819-3825
ISSN
  • 1590-1874 (ISSN-L)
  • 1590-3478
OpenAlex
W4384154426
Cited by
9
References
66
Citations by year
2026: 3 · 2025: 3 · 2024: 3
FWCI
0.24
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Neurological Sciences (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
retigabine, Kv7 channels, KCNQ channels, epilepsy, antiepileptic drugs, M-current, neuronal excitability, positive allosteric modulators, drug-resistant epilepsy, seizure pathophysiology
MeSH terms
Animals, Anticonvulsants, Carbamates, Epilepsy, Humans, Phenylenediamines, KCNQ Potassium Channels

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identifying the mechanism of action of the Kv7 channel opener, retigabine in the treatment of epilepsy. https://app.cochat.ai/papers/10.1007/s10072-023-06955-x
The paper
Zahra, A., Liu, R., Wang, J., & Wu, J. (2023). Identifying the mechanism of action of the Kv7 channel opener, retigabine in the treatment of epilepsy. Neurological Sciences. https://doi.org/10.1007/s10072-023-06955-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.